• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经泌尿生殖综合征:近期数据概述

The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.

作者信息

Angelou Kyveli, Grigoriadis Themos, Diakosavvas Michail, Zacharakis Dimitris, Athanasiou Stavros

机构信息

Urogynecology Unit, Alexandra Hospital-National and Kapodistrian University of Athens, Athens, GRC.

出版信息

Cureus. 2020 Apr 8;12(4):e7586. doi: 10.7759/cureus.7586.

DOI:10.7759/cureus.7586
PMID:32399320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7212735/
Abstract

The genitourinary syndrome of menopause (GSM) is a relatively new term for the condition previously known as vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy. The term was first introduced in 2014. GSM is a chronic, progressive, vulvovaginal, sexual, and lower urinary tract condition characterized by a broad spectrum of signs and symptoms. Most of these symptoms can be attributed to the lack of estrogen that characterizes menopause. Even though the condition mainly affects postmenopausal women, it is seen in many premenopausal women as well. The hypoestrogenic state results in hormonal and anatomical changes in the genitourinary tract, with vaginal dryness, dyspareunia, and reduced lubrication being the most prevalent and bothersome symptoms. These can have a great impact on the quality of life (QOL) of the affected women, especially those who are sexually active. The primary goal of the treatment of GSM is to achieve the relief of symptoms. First-line treatment consists of non-hormonal therapies such as lubricants and moisturizers, while hormonal therapy with local estrogen products is generally considered the "gold standard''. Newer therapeutic approaches with selective estrogen receptor modulators (SERMs) or laser technologies can be employed as alternative options, but further research is required to investigate the viability and scope of their implementation in day-to-day clinical practice.

摘要

更年期泌尿生殖综合征(GSM)是一个相对较新的术语,用于描述以前被称为外阴阴道萎缩、萎缩性阴道炎或泌尿生殖萎缩的病症。该术语于2014年首次提出。GSM是一种慢性、进行性的外阴阴道、性和下尿路病症,其特征是具有广泛的体征和症状。这些症状大多可归因于更年期所特有的雌激素缺乏。尽管该病症主要影响绝经后女性,但在许多绝经前女性中也可见到。雌激素缺乏状态导致泌尿生殖道出现激素和解剖学变化,其中阴道干燥、性交困难和润滑减少是最常见且令人困扰的症状。这些症状会对受影响女性的生活质量(QOL)产生重大影响,尤其是对那些有性生活的女性。治疗GSM的主要目标是缓解症状。一线治疗包括使用润滑剂和保湿剂等非激素疗法,而局部雌激素产品的激素疗法通常被视为“金标准”。选择性雌激素受体调节剂(SERM)或激光技术等新型治疗方法可作为替代选择,但需要进一步研究以探讨其在日常临床实践中的可行性和应用范围。

相似文献

1
The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.绝经泌尿生殖综合征:近期数据概述
Cureus. 2020 Apr 8;12(4):e7586. doi: 10.7759/cureus.7586.
2
Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.更年期泌尿生殖综合征:临床医生的管理策略
Mayo Clin Proc. 2017 Dec;92(12):1842-1849. doi: 10.1016/j.mayocp.2017.08.019.
3
Use of Moisturizers and Lubricants for Vulvovaginal Atrophy.保湿剂和润滑剂在外阴阴道萎缩中的应用。
Front Reprod Health. 2021 Dec 23;3:781353. doi: 10.3389/frph.2021.781353. eCollection 2021.
4
Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.绝经泌尿生殖综合征:临床表现、病理生理学、病因、评估及管理概述
Am J Obstet Gynecol. 2016 Dec;215(6):704-711. doi: 10.1016/j.ajog.2016.07.045. Epub 2016 Jul 26.
5
Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review.绝经后女性泌尿生殖系统综合征的激素治疗和阴道保湿剂:系统评价。
Ann Intern Med. 2024 Oct;177(10):1400-1414. doi: 10.7326/ANNALS-24-00610. Epub 2024 Sep 10.
6
Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.女性癌症患者泌尿生殖系统绝经综合征的管理:关注阴道激素治疗。
Am J Obstet Gynecol. 2020 Feb;222(2):103-113. doi: 10.1016/j.ajog.2019.08.043. Epub 2019 Aug 29.
7
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.二极管阴道激光治疗绝经后泌尿生殖综合征的疗效
Bioengineering (Basel). 2023 Oct 2;10(10):1158. doi: 10.3390/bioengineering10101158.
8
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.应对女性外阴阴道萎缩(VVA)/绝经泌尿生殖综合征(GSM)以促进健康衰老
Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019.
9
Genitourinary Syndrome of Menopause.绝经泌尿生殖综合征
Clin Obstet Gynecol. 2018 Sep;61(3):508-516. doi: 10.1097/GRF.0000000000000380.
10
Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements.更年期泌尿生殖综合征治疗选择的最新进展:激素及非激素管理
J Menopausal Med. 2021 Apr;27(1):1-7. doi: 10.6118/jmm.20034.

引用本文的文献

1
Efficacy of Non-Invasive Monopolar Radiofrequency for Treating Genitourinary Syndrome of Menopause: A Prospective Pilot Study.非侵入性单极射频治疗绝经后泌尿生殖综合征的疗效:一项前瞻性试点研究。
Clin Pract. 2025 Aug 20;15(8):155. doi: 10.3390/clinpract15080155.
2
The Prevalence and Predictive Factors of Genitourinary Syndrome of Menopause in Postmenopausal Women: A Cross-sectional Study.绝经后女性泌尿生殖综合征的患病率及预测因素:一项横断面研究
Int J Community Based Nurs Midwifery. 2025 Jul 1;13(3):213-224. doi: 10.30476/ijcbnm.2025.103010.2529. eCollection 2025 Jul.
3
Is the Addition of CO Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial.在膀胱过度活动症的治疗中,添加CO激光至β3-肾上腺素能受体激动剂米拉贝隆是否有效?一项随机对照试验的结果
Medicina (Kaunas). 2025 Jun 30;61(7):1198. doi: 10.3390/medicina61071198.
4
Sexual Quality of Life in Postmenopausal Women: A Comparative Randomized Controlled Trial of Intravaginal PRP Therapy Versus Local Hormonal Treatments.绝经后女性的性生活质量:阴道内注射富血小板血浆疗法与局部激素治疗的比较随机对照试验
Medicina (Kaunas). 2025 Jun 25;61(7):1140. doi: 10.3390/medicina61071140.
5
Efficacy and safety of Kunxinning granules in patients with menopausal syndrome: a multicenter, randomized, double-blinded, and placebo-controlled trial.坤心宁颗粒治疗更年期综合征患者的疗效与安全性:一项多中心、随机、双盲、安慰剂对照试验
Front Pharmacol. 2025 Jul 10;16:1512110. doi: 10.3389/fphar.2025.1512110. eCollection 2025.
6
Self-efficacy intervention on health literacy and quality of life in menopausal women of suburban areas.自我效能干预对郊区更年期女性健康素养和生活质量的影响
Sci Rep. 2025 Jul 3;15(1):23813. doi: 10.1038/s41598-025-09347-7.
7
Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal Women.绝经后女性内源性雌马酚产生与膀胱过度活动症发病之间的关联。
J Clin Med. 2025 Jun 12;14(12):4183. doi: 10.3390/jcm14124183.
8
[Pathogenetically justified use in real clinical practice of vaginal estriol 0.5 mg in women of different ages].[不同年龄段女性阴道用0.5毫克雌三醇在实际临床实践中的病因学合理应用]
Probl Endokrinol (Mosk). 2025 May 20;71(2):102-108. doi: 10.14341/probl13575.
9
Urinary microbiomes in postmenopausal women with or without urinary symptoms of the genitourinary syndrome of menopause: a cross-sectional study.有或无绝经泌尿生殖综合征泌尿系统症状的绝经后女性的泌尿微生物群:一项横断面研究。
Sci Rep. 2025 Apr 14;15(1):12796. doi: 10.1038/s41598-025-97725-6.
10
Experiences of hot flashes, urinary incontinence and mood among South Asian American women: the MASALA study.南亚裔美国女性潮热、尿失禁及情绪方面的经历:MASALA研究
Climacteric. 2025 Apr 3:1-8. doi: 10.1080/13697137.2025.2480584.

本文引用的文献

1
Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy.绝经后妇科恶性肿瘤女性患者的更年期症状的激素处理。
Menopause. 2020 Feb;27(2):243-248. doi: 10.1097/GME.0000000000001447.
2
Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review.患者报告结局测量指标(PROMs)在女性绝经后泌尿生殖系统综合征中的测量性能:系统评价。
Menopause. 2019 Nov;26(11):1342-1353. doi: 10.1097/GME.0000000000001390.
3
Genitourinary syndrome of menopause.绝经后泌尿生殖系统综合征。
Post Reprod Health. 2020 Jun;26(2):111-114. doi: 10.1177/2053369119884144. Epub 2019 Oct 23.
4
Therapies for the management of genitourinary syndrome of menopause.更年期泌尿生殖综合征的管理疗法。
Post Reprod Health. 2020 Mar;26(1):32-42. doi: 10.1177/2053369119866341. Epub 2019 Aug 6.
5
Genitourinary syndrome of menopause: effects on related factors, quality of life, and self-care power.更年期泌尿生殖综合征:对相关因素、生活质量及自我护理能力的影响
Prz Menopauzalny. 2019 Apr;18(1):15-22. doi: 10.5114/pm.2019.84152. Epub 2019 Apr 9.
6
The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.绝经激素治疗在有或有卵巢癌和乳腺癌风险的妇女中的作用:误解和当前方向。
Cancer. 2019 Feb 15;125(4):499-514. doi: 10.1002/cncr.31911. Epub 2018 Dec 20.
7
Genitourinary Changes with Aging.泌尿系统随增龄改变。
Obstet Gynecol Clin North Am. 2018 Dec;45(4):737-750. doi: 10.1016/j.ogc.2018.07.010. Epub 2018 Oct 25.
8
Genitourinary Syndrome of Menopause.绝经泌尿生殖综合征
Clin Obstet Gynecol. 2018 Sep;61(3):508-516. doi: 10.1097/GRF.0000000000000380.
9
Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations.妇科癌症幸存者的绝经激素治疗:证据综述与实践建议
Clin Obstet Gynecol. 2018 Sep;61(3):488-495. doi: 10.1097/GRF.0000000000000381.
10
Genitourinary syndrome of menopause: Common problem, effective treatments.绝经后泌尿生殖系统综合征:常见问题,有效治疗。
Cleve Clin J Med. 2018 May;85(5):390-398. doi: 10.3949/ccjm.85a.15081.